NCT03188926

Completed

Surgical Treatment of Long Bone Metastases

Istituto Ortopedico Rizzoli Source

Compare

Other study identifiers

Sponsor study identifier

0026106

Study Type

observational

Actual enrollment (reported)

120

Locations

1 country

Sites

1

Timeline

Study Start

January 4, 2016

Actual (reported)

Primary Completion

December 31, 2017

Actual (reported)

Study Completion

January 31, 2020

Actual (reported)

Brief Summary

To provide treatment guidelines for patients with long bone metastatic disease based on observational study and to propose an algorithm to guide orthopedic surgeons in decision-making for these patient.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 120 participants
Study completion date: January 31, 2020
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 4, 2016
Actual (reported)
First Submitted
June 9, 2017
Actual (reported)
First Posted
June 16, 2017
Actual (reported)
Primary Completion
December 31, 2017
Actual (reported)
Study Completion
January 31, 2020
Actual (reported)

Last Updated: August 4, 2020
Status Verified: August 2020
Last Update Submitted: August 2, 2020

Conditions

Bone Metastases Surgery

Outcome Measures

Primary Outcomes (1)

Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction
The objectives of this study were to examine clinical outcomes after reconstruction with intramedullary nail versus endoprosthetic reconstruction with a specific focus on differences in complication rate between patients treated with intramedullary nail versus endoprosthetic reconstruction
1 year

Secondary Outcomes (1)

Survival in patients undergoing surgery for metastatic bone disease
1 year

Interventions

intramedullary fixation or endoprosthetic reconstructionProcedure

Surgical treatment of impending or pathologic fracture in the extremities

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Sexall

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients with long bone metastases treated surgically with intramedullary nail or endoprosthetic reconstruction

You may qualify if:

bone metastases of the extremity

You may not qualify if:

Sponsors & Collaborators

Istituto Ortopedico Rizzoli
Otherlead

Study Sites (1)

Istituto Ortopedico Rizzoli

Bologna, 40136, Italy

Study Officials

Davide Donati, MD
Istituto Ortopedico Rizzoli
STUDY DIRECTOR

Enrollment

120 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Target Duration: 12 Months
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: MD, PhD

Study Record Dates

First Submitted

June 9, 2017

First Posted

June 16, 2017

Study Start

January 4, 2016

Actual (reported)

NCT02376322

Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS

Phase 2Completed

NCT03465839

Bedside Nursing Handovers in the Surgical Context

Not ApplicableCompleted

NCT06524843

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Recruiting

NCT03353090

Double-bed SPECT/CT for Bone Scintigraphy in Initial Staging of Cancer Patients

Completed

NCT03688997

Knot Tying Surgical Simulator for Vessel Ligation

Not ApplicableCompleted

NCT03646734

Guided Bone Regeneration With Particulate Versus Block Graft

Completed

bone metastases of the spine

Contact the study team to confirm eligibility.

Primary Completion

December 31, 2017

Actual (reported)

Study Completion

January 31, 2020

Actual (reported)

Last Updated

August 4, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing: Will share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03188926
Data provider: ClinicalTrials.gov
Source updated: 2020-08-04
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:30:17 UTC

Locations

IT(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations